Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

65.9K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.9K
What is the Cell Cycle?00:56

What is the Cell Cycle?

10.5K
The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
10.5K
What is the Cell Cycle?01:04

What is the Cell Cycle?

242.6K
The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the original...
242.6K
Pyruvate Oxidation01:15

Pyruvate Oxidation

168.7K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subtype-Stratified Consensus Gene Signatures: Bridging Tumor Cell Biology, Immune Microenvironment, and Clinical Prognosis in Breast Cancer.

International journal of molecular sciences·2026
Same author

Establishing a long-term versatile culture system for functional mouse mammary organoids from single cells.

Nature protocols·2026
Same author

Distinct mammary stem cells orchestrate long-term homeostasis of adult mammary gland.

Cell discovery·2025
Same author

Midkine at the Crossroads of Aging and Cancer.

Cancer research·2024
Same author

Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer.

Nature communications·2024
Same author

Nucleotide at position 66 of NS2A in Japanese encephalitis virus is associated with the virulence and proliferation of virus.

Virus genes·2023

Related Experiment Video

Updated: Jan 29, 2026

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry
11:23

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry

Published on: May 22, 2012

21.6K

The Taurine-Slc6a6 Axis Promotes Breast Cancer Progression by Alleviating Oxidative Stress and Accelerating Cell

Pei Cai1,2,3, Xiaoqin Liu2,3,4, Meizhen Lin1,2,3

  • 1Westlake Institute for Advanced Study, Fudan University, Shanghai 310018, China.

Cells
|January 28, 2026
PubMed
Summary

Elevated Taurine levels and its transporter Slc6a6 promote cancer growth by enhancing antioxidant capacity and cell cycle progression. High SLC6A6 expression indicates poor breast cancer prognosis, suggesting it as a therapeutic target.

Keywords:
Slc6a6Taurinebreast cancer

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.5K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry
11:23

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry

Published on: May 22, 2012

21.6K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.5K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Taurine metabolism's role in cancer is under investigation.
  • The specific functions of the taurine transporter Slc6a6 in tumorigenesis require elucidation.

Purpose of the Study:

  • To investigate the association between Taurine, Slc6a6, and tumor progression.
  • To elucidate the mechanisms by which Slc6a6 influences cancer cell behavior.
  • To assess the clinical relevance of SLC6A6 in breast cancer.

Main Methods:

  • Analysis of serum Taurine levels and Slc6a6 expression in tumor samples.
  • In vivo and in vitro experiments to assess Slc6a6's functional impact on tumor growth and cell proliferation.
  • Mechanistic studies to identify Slc6a6's molecular interactions and functions.
  • Bioinformatics analysis of patient data to correlate SLC6A6 expression with clinical outcomes.

Main Results:

  • Elevated serum Taurine and Slc6a6 upregulation correlate with enhanced tumor growth.
  • Slc6a6 overexpression promotes tumor progression in vivo and accelerates cancer cell proliferation in vitro.
  • Slc6a6 exhibits dual pro-oncogenic functions: mediating Taurine uptake for antioxidant defense and interacting with Rprd1b to promote cell cycle progression.
  • High SLC6A6 expression is linked to poor prognosis in breast cancer patients.

Conclusions:

  • Slc6a6 plays a significant pro-oncogenic role in cancer progression through both metabolic and direct cell cycle regulatory functions.
  • Slc6a6 represents a potential therapeutic target for breast cancer treatment.